ALLO EPS Estimates
Allogene Therapeutics, Inc.
$1.30
+$0.01(+0.78%)
30
Overall
60
Value
9
Tech
21
Quality
Market Cap
$449.14M
Volume
7.73M
52W Range
$1.04 - $4.46
Target Price
$8.30
ALLO EPS estimates: the consensus estimate for Allogene Therapeutics, Inc.'s current fiscal year is -$0.59 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
ALLO EPS Estimates
- EPS estimate, current quarter
- $-0.13
- EPS estimate, next quarter
- $-0.14
- EPS estimate, current year
- $-0.59
- EPS estimate, next year
- $-0.60
- EPS growth, 3-year
- +27.89%
| Fiscal year | EPS |
|---|---|
| 2025 | $-0.87 |
| 2024 | $-1.32 |
| 2023 | $-2.09 |
| 2022 | $-2.32 |
| 2021 | $-1.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $1.30 | +0.8% | 7.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW